Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03065231 · ClinicalTrials.gov registry record · NA

Lumbar Drain vs Extraventricular Drain to Prevent Vasospasm in Subarachnoid Hemorrhage

A NA study of Subarachnoid Hemorrhage and Vasospasm, Intracranial, sponsored by University of California, San Diego.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT03065231: Recruiting NA study of Subarachnoid Hemorrhage and Vasospasm, Intracranial, sponsored by University of California, San Diego.

NCT03065231 is a NA study of Subarachnoid Hemorrhage and Vasospasm, Intracranial that is actively recruiting participants, run by University of California, San Diego. The registered enrollment target is 100 participants, below the 3,583-participant average among 21 other Subarachnoid Hemorrhage trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03065231, a NA study of Subarachnoid Hemorrhage and Vasospasm, Intracranial, is actively recruiting participants, sponsored by University of California, San Diego.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

Vasospasm is a common complication after rupture of intracranial aneurysms causing devastating neurologic deficits and death. Vasospasm has been directly associated with the amount of subarachnoid blood inside the basal cisterns. Prior literature has attempted to refine treatment of ruptured intracranial aneurysms but does not have clear guidelines on the optimal method to drain subarachnoid blood. Two methods, extraventricular drain (EVD) and lumbar drain (LD) have been compared retrospectively yet remain controversial as to which method is optimal in reducing subarachnoid blood and preventing vasospasm. This study would be a prospective randomized trial in which patients would be assigned to EVD or LD and observed to see if one method of intervention is associated with preventing clinical vasospasm, decreasing subarachnoid blood, shortening overall ICU stay, and reducing the need for a permanent ventriculoperitoneal shunt. The conclusions of this study may identify an optimal treatment modality to benefit all future patients with ruptured intracranial aneurysms.

Primary Outcome

Clinical and Radiographic incidence of vasospasm after ruptured intracranial aneurysm

Interventions

  • DEVICE Extraventricular Drain
  • DEVICE Lumbar Drain

Study Locations (1)

California

  • UCSD Medical Center - San Diego

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2017-01-01
Est. Completion 2027-01-04
Phase NA
University of California, San Diego

775 total trials

What NCT03065231 shows while recruiting

NCT03065231 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 3,583-participant average among 21 other Subarachnoid Hemorrhage trials with a reported enrollment target (97% lower).

The record links to 2 conditions, with Subarachnoid Hemorrhage appearing as the primary indexed condition, and to 2 interventions - of which Extraventricular Drain is the first listed.

NCT03065231 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT03065231 about?

NCT03065231 is a clinical study titled "Lumbar Drain vs Extraventricular Drain to Prevent Vasospasm in Subarachnoid Hemorrhage". Vasospasm is a common complication after rupture of intracranial aneurysms causing devastating neurologic deficits and death. Vasospasm has been directly associated with the amount of subarachnoid blood inside the basal cisterns. Prior literature has attempted to refine treatment of ruptured intracr...

What is the current status of trial NCT03065231?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2017-01-01. Estimated completion is 2027-01-04.

What conditions does trial NCT03065231 study?

This clinical trial studies the following conditions: Subarachnoid Hemorrhage, Vasospasm, Intracranial.

What interventions are being tested in trial NCT03065231?

The interventions under investigation include: Extraventricular Drain (DEVICE), Lumbar Drain (DEVICE).

Who is sponsoring clinical trial NCT03065231?

This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03065231 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Subarachnoid Hemorrhage

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03065231's enrollment target sits among peer trials

100 11th of 21 higher than 11 of 21 other Subarachnoid Hemorrhage trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Subarachnoid Hemorrhage trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03065231, the US trial registry maintained by the National Library of Medicine. NCT03065231 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.